TRANSDERMAL DRUG DELIVERY SYSTEM: A COMPREHENSIVE OVERVIEW OF RECENT PROGRESS AND ENHANCEMENT STRATEGIES

Abstract

Transdermal drug delivery systems have emerged as a research issue of interest in the pharmaceutical technology field, as well as one of the most commonly procured pharmaceutical products in the global market. The associated disadvantages of other delivery routes, including oral and parenteral, can be overcome by the use of these systems. The authors will examine the existing tendencies and the way transdermal technologies will be applied in the future, paying particular attention to the development of detailed insight into transdermal drug delivery systems and improvement strategies. The largest organ in the body is the skin, which is a good location for the administration of several medicines. There are various benefits of transdermal drug delivery systems compared to traditional delivery systems. Also, transdermal drug delivery systems [TDDS] offer extended therapeutic levels, decreased side effects, elevated bioavailability, elevated patient compliance, and simple discontinuation of drug treatment. In the article, I will first discuss each of the transdermal enhancement procedures applied in the creation of first-generation transdermal products.